- Research works
- 55 ▲ 108% vs 2013–17
- Citations
- 927 16.9 per fractional work
- Top-10% rate
- 15.6% record average 16.5%
- Open access
- 45% world 28%
Not ranked overall: Enanta Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Enanta Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Vaccine Development, Human Metapneumovirus, Respiratory Syncytial Virus, Treatment, Antimicrobial Resistance, Immune Response and Clinical Practice Guidelines.
- Biological Evaluation
- Peptide Synthesis
- Foldamers
- Olefin Metathesis
- Anticancer Agents
- Ribavirin
- Transcriptional Regulation
- Hepatocellular Carcinoma
- Medicinal Chemistry
- Pandemic
- Antiretroviral Therapy
- Genomics
- Synthesis
- Cancer
- Pneumococcal Conjugate Vaccine
- Pathogenesis
- Immune Response
- Inflammation
- Respiratory Syncytial Virus
- Vaccine Development
- Epidemiology
- Human Metapneumovirus
- Treatment
- Antimicrobial Resistance
- Clinical Practice Guidelines
- Community-Acquired Pneumonia
- Diagnosis
- Antiviral Therapy
- Enantioselective Synthesis
- Liver Disease
- Drug Discovery
- Genetic Variation
- Vaccine
- Immunosuppressive Therapy
- Hepatitis C Virus
- Antibiotic Resistance
- Nuclear Receptors
- Ruthenium Catalysts
- Influenza
- Virus
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology16▲ 7.1×18 topics
- Vaccine Development5▲ 29×3 topics
- Human Metapneumovirus4▲ 163×1 topic
- Respiratory Syncytial Virus4▲ 163×1 topic
- Treatment4▲ 5.7×5 topics
- Inflammation4▲ 2.9×10 topics
- Antimicrobial Resistance3▲ 25×2 topics
- Immune Response3▲ 9.6×7 topics
- Clinical Practice Guidelines3▲ 10×2 topics
- Pathogenesis3▲ 10×8 topics
- Community-Acquired Pneumonia3▲ 125×1 topic
- Pneumococcal Conjugate Vaccine3▲ 125×1 topic
- Diagnosis3▲ 4.5×5 topics
- Cancer2▲ 3.2×11 topics
- Antiviral Therapy2▲ 29×3 topics
- Synthesis2▲ 7.5×7 topics
- Enantioselective Synthesis2▲ 24×3 topics
- Genomics2▲ 11×3 topics
- Liver Disease2▲ 29×2 topics
- Antiretroviral Therapy2▲ 15×2 topics
- Drug Discovery2▲ 8.8×3 topics
- Pandemic2▲ 7.6×3 topics
- Genetic Variation2▲ 10×2 topics
- Medicinal Chemistry2▲ 8.7×4 topics
- Vaccine2▲ 7.7×7 topics
- Hepatocellular Carcinoma2▲ 13×2 topics
- Immunosuppressive Therapy2▲ 15×2 topics
- Transcriptional Regulation2▲ 12×2 topics
- Hepatitis C Virus2▲ 51×1 topic
- Ribavirin2▲ 51×1 topic
- Antibiotic Resistance1▲ 6.4×4 topics
- Anticancer Agents1▲ 10×3 topics
- Nuclear Receptors1▲ 14×2 topics
- Olefin Metathesis1▲ 44×1 topic
- Ruthenium Catalysts1▲ 44×1 topic
- Foldamers1▲ 29×1 topic
- Influenza1▲ 51×1 topic
- Peptide Synthesis1▲ 29×1 topic
- Virus1▲ 20×1 topic
- Biological Evaluation1▲ 18×3 topics
Which research topics does Enanta Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Respiratory viral infections research, Influenza Virus Research Studies, Viral Infections and Immunology Research and Liver Disease Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections research Epidemiology 2 works
- 2 Influenza Virus Research Studies Epidemiology 1 works
- 3 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 1 works
- 4 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 6 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
- 7 Drug Transport and Resistance Mechanisms Oncology 0 works
- 8 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 9 Virus-based gene therapy research Genetics 0 works
- 10 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Enanta Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 108% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Watertown
- Boston Biomedical Research Institute
- Primary Source
- Cambridge Scientific (United States)
- Radiation Monitoring Devices (United States)
- Arsenal Medical (United States)
- Pathfinder International
- New England Research Institutes
- Perkins School for Blind
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.